About the journal
The Cancer Journal is a journal published by Lippincott Williams & Wilkins in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Lippincott Williams & Wilkins
- ISSN
- 1528-9117 · 1540-336X
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://www.journalppo.com
Index listings
- MEDLINE · 2000-01-01
- Indexing
- MEDLINE
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 28 days received→accepted — computed from PubMed (n=88)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1926
Last recorded publication year
2026
h-index
113
i10-index
1050
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 49%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 100931981
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- CAR-T cell therapy research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
Show all subjects (50)
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Lymphoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lymphoma Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Cancer survivorship and care
- Cancer survivorship and care
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Medical Imaging Techniques and Applications
- Medical Imaging Techniques and Applications
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Surgical Treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ